{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:36:00Z","timestamp":1793298960574,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,21]],"date-time":"2019-11-21T00:00:00Z","timestamp":1574294400000},"content-version":"vor","delay-in-days":2790,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1093\/annonc\/mdr350","type":"journal-article","created":{"date-parts":[[2011,8,11]],"date-time":"2011-08-11T06:14:33Z","timestamp":1313043273000},"page":"948-954","source":"Crossref","is-referenced-by-count":97,"title":["The initial change in tumor size predicts response and survival in patients with metastatic colorectal cancer treated with combination chemotherapy"],"prefix":"10.1016","volume":"23","author":[{"given":"C.","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Blomqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sundin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Jacobsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bystr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5.","family":"Berglund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Nygren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Glimelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdr350_bb0010","author":"WHO Handbook for Reporting Results of Cancer Treatment","year":"1979"},{"key":"10.1093\/annonc\/mdr350_bb0015","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdr350_bb0020","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdr350_bb0025","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/1097-0142(197607)38:1<388::AID-CNCR2820380156>3.0.CO;2-A","article-title":"The effect of measuring error on the results of therapeutic trials in advanced cancer","volume":"38","author":"Moertel","year":"1976","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdr350_bb0030","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/jnci\/91.6.523","article-title":"Measuring response in solid tumors: unidimensional versus bidimensional measurement","volume":"91","author":"James","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdr350_bb0035","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1093\/jnci\/djm024","article-title":"Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials","volume":"99","author":"Punt","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1093\/annonc\/mdr350_bb0040","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/bjc.1994.345","article-title":"The relationship between an objective response to chemotherapy and survival in advanced colorectal cancer","volume":"70","author":"Graf","year":"1994","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdr350_bb0045","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1002\/(SICI)1097-0258(19961230)15:24<2797::AID-SIM290>3.0.CO;2-V","article-title":"On the relationship between response to treatment and survival time","volume":"15","author":"Buyse","year":"1996","journal-title":"Stat Med"},{"key":"10.1093\/annonc\/mdr350_bb0050","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0140-6736(00)02528-9","article-title":"Relation between tumour response to first-line chemotherapy and survival in advanced colorectal cancer: a meta-analysis. Meta-Analysis Group in Cancer","volume":"356","author":"Buyse","year":"2000","journal-title":"Lancet"},{"key":"10.1093\/annonc\/mdr350_bb0055","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1093\/annonc\/mdm496","article-title":"KRAS wild-type state predicts survival and is associated to early radiological response in metastatic colorectal cancer treated with cetuximab","volume":"19","author":"De Roock","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdr350_bb0060","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/annonc\/mdp011","article-title":"Radiological tumor size decrease at week 6 is a potent predictor of outcome in chemorefractory metastatic colorectal cancer treated with cetuximab (BOND trial)","volume":"20","author":"Piessevaux","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdr350_bb0065","first-page":"1480","article-title":"Prognostic aspects of 18F-FDG PET kinetics in patients with metastatic colorectal carcinoma receiving FOLFOX chemotherapy","volume":"45","author":"Dimitrakopoulou-Strauss","year":"2004","journal-title":"J Nucl Med"},{"key":"10.1093\/annonc\/mdr350_bb0070","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/annonc\/mdm470","article-title":"Chemotherapy response evaluation with FDG-PET in patients with colorectal cancer","volume":"19","author":"de Geus-Oei","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdr350_bb0075","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/annonc\/mdn744","article-title":"Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer","volume":"20","author":"Bystrom","year":"2009","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdr350_bb0080","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/archsurg.2010.41","article-title":"Effectiveness of positron emission tomography for predicting chemotherapy response in colorectal cancer liver metastases","volume":"145","author":"Glazer","year":"2010","journal-title":"Arch Surg"},{"key":"10.1093\/annonc\/mdr350_bb0085","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1200\/JCO.2008.21.0807","article-title":"Model-based prediction of phase III overall survival in colorectal cancer on the basis of phase II tumor dynamics","volume":"27","author":"Claret","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr350_bb0090","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/annonc\/mdm588","article-title":"A randomized phase III multicenter trial comparing irinotecan in combination with the Nordic bolus 5-FU and folinic acid schedule or the bolus\/infused de Gramont schedule (Lv5FU2) in patients with metastatic colorectal cancer","volume":"19","author":"Glimelius","year":"2008","journal-title":"Ann Oncol"},{"issue":"21","key":"10.1093\/annonc\/mdr350_bb0095","first-page":"viii193","article-title":"Early tumor shrinkage for the prediction of efficacy of cetuximab in metastatic colorectal cancer (mCRC): analysis from the CRYSTAL study. Abstracts of the 35th European Society for Medical Oncology Conference. October 8\u201312, 2010. Milan, Italy","author":"Piessevaux","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdr350_bb0100","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1080\/02841860701829679","article-title":"Radiological assessment of tumour response to anti-cancer drugs: time to reappraise","volume":"47","author":"Nygren","year":"2008","journal-title":"Acta Oncol"},{"key":"10.1093\/annonc\/mdr350_bb0105","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1200\/JCO.2006.07.3049","article-title":"Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria","volume":"25","author":"Choi","year":"2007","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"10.1093\/annonc\/mdr350_bb0110","doi-asserted-by":"crossref","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","article-title":"From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors","volume":"50","author":"Wahl","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1093\/annonc\/mdr350_bb0115","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1080\/02841860152708251","article-title":"The case against apoptosis","volume":"40","author":"Steel","year":"2001","journal-title":"Acta Oncol"},{"key":"10.1093\/annonc\/mdr350_bb0120","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1007\/s00330-008-0866-4","article-title":"Semi-automated volumetric analysis of lymph node metastases in patients with malignant melanoma stage III\/IV-A feasibility study","volume":"18","author":"Fabel","year":"2008","journal-title":"Eur Radiol"},{"key":"10.1093\/annonc\/mdr350_bb0125","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1200\/JCO.2003.01.144","article-title":"Interobserver and intraobserver variability in measurement of non-small-cell carcinoma lung lesions: implications for assessment of tumor response","volume":"21","author":"Erasmus","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdr350_bb0130","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00330-005-0036-x","article-title":"Inadequacy of manual measurements compared to automated CT volumetry in assessment of treatment response of pulmonary metastases using RECIST criteria","volume":"16","author":"Marten","year":"2006","journal-title":"Eur Radiol"},{"key":"10.1093\/annonc\/mdr350_bb0135","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.2967\/jnumed.109.063321","article-title":"Assessment of interobserver reproducibility in quantitative 18F-FDG PET and CT measurements of tumor response to therapy","volume":"50","author":"Jacene","year":"2009","journal-title":"J Nucl Med"},{"key":"10.1093\/annonc\/mdr350_bb0140","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1200\/JCO.2000.18.10.2179","article-title":"Evaluation of tumor measurements in oncology: use of film-based and electronic techniques","volume":"18","author":"Schwartz","year":"2000","journal-title":"J Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419346496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419346496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/23\/4\/948\/19446272\/mdr350.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,28]],"date-time":"2021-07-28T13:14:34Z","timestamp":1627478074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419346496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0923753419346496"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdr350","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}